Rxwire
In the news · 48h FDA 37 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 Novo Nordisk 3 AbbVie 2
Trials & R&D · first seen 12h ago, updated 12h ago

Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial

1 outlet Merck & Co. (MSD)

Coverage 1 article · 1 outlet

  1. Seeking Alpha Healthcare
    Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial